AIMT Stock Posts


AIMT stock increases 2.6% after hours.

After Hours Gainer

AIMT Aimmune Therapeutics Inc.22.75-2.32-9.3%

After Hours:23.35+0.60 (+2.6%)

Aimmune Therapeutics Submits BLA to FDA for AR101 for the Treatment of Peanut Allergy in Children and Adolescents Ages 417

Business WireFri, 21-Dec 4:01 PM

AIMT stock increases 2.7% after hours.

After Hours Gainer

AIMT Aimmune Therapeutics Inc.22.75-2.32-9.3%

After Hours:23.36+0.61 (+2.7%)

Aimmune Therapeutics Submits BLA to FDA for AR101 for the Treatment of Peanut Allergy in Children and Adolescents Ages 417

Business WireFri, 21-Dec 4:01 PM

Unusual Option Volume

AIMT Aimmune Therapeutics Inc.23.98+2.27 (+10.5%)

AIMT stock increases 13.8% in premarket,

Premarket Gainer

AIMT Aimmune Therapeutics Inc.21.71-0.26-1.2%

Premarket:24.70+2.99 (+13.8%)

Aimmune Therapeutics Announces IND Filing for AR201 for Egg Allergy and Exclusive Supply Agreement with Michael Foods

Business WireThu, 20-Dec 8:00 AM

$AIMT 16-Nov-18 Straddle Implies a ±6.6% move. Nov 15 Jefferies 2018 London Healthcare Conference
$AIMT 16-Nov-18 Straddle Implies a ±6.6% move. Nov 14 27th Annual Credit Suisse Healthcare Conference

Wait, Before You Leave...